Xencor | Driftskostnader



Operating Expenses Endring Dato
AbbVie USD 9.61B 6.98B 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Arrowhead Research USD 163.91M 1.71M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Cytokinetics USD 155.97M 14.7M 2024-12
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
J&J USD 8.26B 10.37B 2025-03
MacroGenics USD 35.94M 20.58M 2024-12
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Xencor USD 65.97M 7.02M 2024-12



Xencor Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.